People with cystic fibrosis-related diabetes (CFRD) show alterations in the lung microbiome, the community of microbes that live in the…
Andrea Lobo, PhD
Andrea Lobo holds a Biology degree, and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Low- and ultra-low-dose lung CT scans may help monitor how people with cystic fibrosis (CF) respond to CFTR…
Among people with cystic fibrosis (CF) who develop kidney failure, getting a kidney transplant may extend survival by nearly…
High-intensity interval training (HIIT), which alternates short periods of intense effort with equally short recovery periods, is safe and a…
One year of treatment with Trikafta modestly eased some digestive symptoms and led to fewer reports of constipation in children…
Lower insulin doses and less blood sugar variability were observed one year after adults with cystic fibrosis-related diabetes (CFRD)…
The amount of physical activity children and adolescents with cystic fibrosis (CF) get is linked to their age, physical…
About one-quarter of children with cystic fibrosis (CF) who are hospitalized for pulmonary exacerbations — an acute worsening of…
Kidney failure, when the kidneys no longer work on their own, is up to 29 times more common in people…
Trikafta safely improved lung function and reduced exacerbations in people with cystic fibrosis (CF) who started treatment after…